Site navigation

Navigation

Hyperparathyroidism - cinacalcet

Cinacalcet for the treatment of secondary hyperparathyroidism in patients with end-stage renal disease on maintenance dialysis therapy

Summary

Cinacalcet is not generally recommended for treating people on dialysis who have hyperparathyroidism because of their kidney disease. However, it is recommended for people on dialysis who: have very high levels of parathyroid hormone in their blood that can't be lowered by other treatme ...

Read the complete summary


Guidance documents

Implementing this guidance

Other information

We will consult on our review plans for this guidance in December 2009

About this guidance

Technology appraisals TA117

Issued: January 2007

How this guidance was produced

See also:

See this guidance in practice:

Order printed copies of this guidance